跳至主要内容
临床试验/NCT01779895
NCT01779895已完成不适用

Effect of Probiotic Lactobacillus Paracasei NCC2461 on House Dust Mite Allergy

Société des Produits Nestlé (SPN)2 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2012年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64
试验地点
2
主要终点
Quality of life, measured by a validated mini rhinoconjunctivitis quality of life questionnaire (MiniRQLQ)

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of a probiotic strain in improving the quality of life in adult subjects suffering from perennial allergic rhinit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults between 20-65 years old
  • Confirmed allergy (allergic rhinitis) to dust mite for more than 2 years, as determined by anamnesis and by a miniRQLQ of ≥ 1
  • Positive Skin prick testing measure greater than 3mm wheal diameter to the dermatophagoides pteronyssinus species of house dust mite extract
  • Body Mass Index 19-29
  • Having obtained his/her informed consent

排除标准

  • Allergy to any food or medication
  • Family history of congenital immunodeficiency or chronic consumption (more than one week at Screening) of immunosuppressive or anti-inflammatory treatments
  • Ongoing treatment with antibiotics or undergoing allergen immunotherapy at Screening
  • Consumption of probiotic and other dietary nutritional interventions
  • More than 2 drinks/day alcohol consumption or use of illicit drugs
  • Pregnant women
  • Subjects with expected low compliance
  • Blood donation in the past month or planning to donate blood until a month after the end of the study
  • Currently participating or having participated in another interventional clinical trial during the last four weeks prior to the beginning the study

结局指标

主要结局

Quality of life, measured by a validated mini rhinoconjunctivitis quality of life questionnaire (MiniRQLQ)

时间窗: 8 weeks

Compared over 8 weeks between the two treatment groups

次要结局

  • Basophil activation in ex-vivo stimulated whole blood cells(Measured 3 times: at the start of product intake, after 4 weeks and after 8 weeks)
  • Level of pro-inflammatory cytokines in ex-vivo stimulated whole blood cells(Measured 3 times: at the start of product intake, after 4 weeks and after 8 weeks)
  • Total Nasal Symptom Score (TNSS), Total Ocular Symptom Score (TOSS), Medication score(Measured weekly for the 8 weeks of product intake)
  • Level of Specific Immunoglobulin E(Measured 2 times: at the start of product intake and after 8 weeks)
  • Frequency of adverse events(during the 8 weeks of product intake)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验